Author

Mikko Siurala

Parker Institute for Cancer Immunotherapy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

Amanda FinckiD· 1 shared Carl H. JuneiD· 1 shared Charles‐Antoine AssenmacheriD· 1 shared Maria Angela AznariD· 1 shared Philipp C. RommeliD· 1 shared Regina M. YoungiD· 1 shared Sebastian J Atoche· 1 shared Sofía Castelli· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amanda FinckORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing anti-tumor efficacy

Sofía Castelli, Wesley V. Wilson, Uğur Uslu, Amanda Finck, Philipp C. Rommel, Charles‐Antoine Assenmacher, Sebastian J Atoche, Mikko Siurala, Maria Angela Aznar, Regina M. Young, Carl H. June

This study shows that adding IL-9 signaling to CAR T cells improves their anti-tumor effectiveness by shifting their fate toward memory and cycling states.

Immunity · Nov 21, 2025Peer-reviewedImmunology